Evolution of in vitro antimicrobial resistance in an equine hospital over 3 decades

Annie Malo1, Caroline Cluzel1, Olivia Labrecque1

  • 1Department of Clinical Sciences (Malo, Lavoie, Leclere), Department of Pathology and Microbiology (Cluzel), Veterinary Biomedicine Department (Beauchamp), Faculty of Veterinary Medicine, Université de Montréal, 3200 Sicotte, St. Hyacinthe, Quebec J2S 7C6; Laboratoire d'épidémiosurveillance animale, Ministère de l'Agriculture des Pêcheries et de l'Alimentation du Québec, St. Hyacinthe, Quebec (Labrecque).

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.9K
Antibiotic Selection00:57

Antibiotic Selection

Overview
61.9K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
1.8K
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
236